University Hopsital Tuebingen
Welcome,         Profile    Billing    Logout  
 0 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lengerke, Claudia
NCT03897127: Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagnosed AML and Intermediate- or Adverse Genetics

Recruiting
3
882
Europe
Cytarabine, Daunorubicin, CPX-351
University of Ulm, Jazz Pharmaceuticals
Acute Myeloid Leukemia
06/27
06/27
NCT04628026: Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

Recruiting
3
650
Europe
Venetoclax, Placebo, Standard chemotherapy, Autologous stem cell transplantation, Allogeneic stem cell transplantation
University of Ulm, Stichting Hemato-Oncologie voor Volwassenen Nederland
Acute Myeloid Leukemia, Myelodysplastic Syndromes
02/25
02/31
NCT06652438: Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

Not yet recruiting
3
415
Europe
Revumenib, Placebo
Stichting Hemato-Oncologie voor Volwassenen Nederland, German-Austrian Acute Myeloid Leukemia Study Group, United Kingdom AML Research Network
Acute Myeloid Leukemia, Adult
05/28
05/31
VenSwitch, NCT06156579: Combination Salvage Therapy With Venetoclax and Decitabine in Relapsed/Refractory AML

Recruiting
2
27
Europe
Decitabine, Dacogen, Venetoclax, Venclyxto, Venclexta
University Hospital Tuebingen
AML, MDS
12/24
03/25
AMLSG BiO, NCT01252485: Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - the Biology and Outcome (BiO)-Project

Recruiting
N/A
50000
Europe
University of Ulm
Acute Myeloid Leukemia (AML), MDS/AML
12/44
12/44
SYS01, NCT05787964: Immunity to Infection in Healthy Participants and Participants With Cancer

Active, not recruiting
N/A
200
Europe
Biological sample collection
University Hospital Tuebingen
Influenza, SARS-CoV-2, Hematologic Malignancy, Solid Tumor
09/24
09/24
Wimmers, Florian
SYS01, NCT05787964: Immunity to Infection in Healthy Participants and Participants With Cancer

Active, not recruiting
N/A
200
Europe
Biological sample collection
University Hospital Tuebingen
Influenza, SARS-CoV-2, Hematologic Malignancy, Solid Tumor
09/24
09/24

Download Options